213 results on '"Kyotani S"'
Search Results
2. The Frequency of Positive Antinuclear Antibodies (ANA) is Low in Patients with Idiopathic and Familial Pulmonary Arterial Hypertension (I/F-PAH) Who have TGF-beta superfamily receptor gene mutations: MS-2-1
3. Acceleration of paraquat adsorption onto chitosan by the presence of sodium chloride
4. Oral beraprost sodium improves exercise capacity and ventilatory efficiency in patients with primary or thromboembolic pulmonary hypertension
5. Acute and chronic effects of surgical thromboendarterectomy on exercise capacity and ventilatory efficiency in patients with chronic thromboembolic pulmonary hypertension
6. Haemodynamic and hormonal effects of adrenomedullin in patients with pulmonary hypertension
7. Haemodynamic correlates and prognostic significance of serum uric acid in adult patients with Eisenmenger syndrome
8. Impaired left ventricular myocardial metabolism in patients with pulmonary hypertension detected by radionuclide imaging
9. Marked efficacy of combined three-drug therapy (Sodium Valproate, Topiramate and Stiripentol) in a patient with Dravet syndrome
10. Haemodynamic correlates and prognostic significance of serum uric acid in adult patients with Eisenmenger syndrome
11. Chlorambucil central nervous toxicity: a significant side effect of chlorambucil therapy in childhood nephrotic syndrome
12. Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension
13. Improvement in exercise capacity with nitric oxide inhalation in patients with precapillary pulmonary hypertension.
14. Marked efficacy of combined three‐drug therapy (Sodium Valproate, Topiramate and Stiripentol) in a patient with Dravet syndrome.
15. Long-Term Haemodynamic Outcome after Pulmonary Endarterectomy for Japanese Chronic Thromboembolic Pulmonary Hypertension.
16. Value of strain and strain rate imaging in predicting adverse outcomes in patients with chronic pulmonary arterial hypertension
17. Th-P15:67 Hypertriglyceridemia occurs through arterio-venous shunt followed by microcirculation disturbances in arterioles -perfusion metabolism theory
18. We-P13:335 Association between high-sensitive C-reactive protein and high-molecular weight adiponectin in Japanese general population
19. PERFUSION METABOLISM THEORY FOR METABOLIC SYNDROME
20. Role of genetic factors (CETP gene Taq I B polymorphism and Apo A-I gene Msp I polymorphism) in serum HDL-C levels in women
21. 4P-0936 Influence of plasma homocysteine concentration on plaque appearance and effects of folate intake and smoking on serum folic acid concentrations in Japanese
22. 1P-0305 Concept of habitual cigarette smoking syndrome - A syndrome with chronic CO toxicosis and hypernicotinemia
23. 4P-0954 Evaluation of apolipoprotein B-100 (apoB) fragmentation and cross-link in serum as a mechanism-based index of atherosclerosis
24. Long term change in atherosclerosis of human abdominal aorta observed by enhanced CT
25. Infective Endocarditis Caused by an Unusual Gram-Negative Rod, Rahnella aquatilis
26. Subepicardial Microischemia Formation Induced by Epicardial Application of Endothelin-1
27. Long-term trial of bosentan monotherapy for pulmonary arterial hypertension in Japanese patients.
28. Effects of adrenomedullin inhalation on hemodynamics and exercise capacity in patients with idiopathic pulmonary arterial hypertension.
29. Increase in thrombomodulin concentrations after pulmonary thromboendarterectomy in chronic thromboembolic pulmonary hypertension.
30. Oral beraprost sodium improves exercise capacity and ventilatory efficiency in patients with primary or thromboembolic pulmonary hypertension.
31. Increased plasma P-selectin and decreased thrombomodulin in pulmonary arterial hypertension were improved by continuous prostacyclin therapy.
32. Gene transfer of human prostacyclin synthase ameliorates monocrotaline-induced pulmonary hypertension in rats.
33. Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension.
34. Surgical treatment for chronic thromboembolic pulmonary hypertension under profound hypothermia and circulatory arrest in 24 patients.
35. KATP channels predominantly regulate conduit vessel tone in normoxic cat pulmonary arteries in vivo
36. Haemodynamic and hormonal effects of adrenomedullin in patients with pulmonary hypertension
37. In vitro paraquat removal with granular chitosan
38. Long-term effect of pravastatin on human atherosclerosis evaluated by a new quantitative image analysis using computed tomography in the lower abdominal aorta
39. Expression of matrix Gla protein and osteonectin mRNA by vascular smooth muscle cells in human aortas
40. Shortening of Doppler-derived deceleration time of early diastolic transmitral flow in the presence of pulmonary hypertension through ventricular interaction.
41. Mutations of the TGF-β type II receptorBMPR2 in pulmonary arterial hypertension
42. Assessment of oxidative stress in autism spectrum disorder using reactive oxygen metabolites and biological antioxidant potential.
43. Evaluation of the efficacy of drug treatment based on measurement of the oxidative stress, using reactive oxygen metabolites and biological antioxidant potential, in children with autism spectrum disorder and attention deficit hyperactivity disorder.
44. Three cases in which drug-induced hyponatremia was improved by replacing carbamazepine with lacosamide.
45. Evaluation of oxidative stress and antioxidant capacity in healthy children.
46. Influence of nanoparticle size on the skin penetration, skin retention and anti-inflammatory activity of non-steroidal anti-inflammatory drugs.
47. Impact of Oxidative Stress and Newer Antiepileptic Drugs on the Albumin and Cortisol Value in Severe Motor and Intellectual Disabilities With Epilepsy.
48. A study of oxidative stress and the newer antiepileptic drugs in epilepsy associated with severe motor and intellectual disabilities.
49. Oxidative Stress Measurement and Prediction of Epileptic Seizure in Children and Adults With Severe Motor and Intellectual Disabilities.
50. Time-course of ventilation, arterial and pulmonary CO(2) tension during CO (2) increase in humans.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.